Sidra Batool | DNA Sequencing | Women Researcher Award 

Posted on by PencisLeave a Comment on Sidra Batool | DNA Sequencing | Women Researcher Award 

Dr. Sidra Batool | DNA Sequencing | Women Researcher Award 

Abdul Wali Khan University Mardan | Pakistan

Author Profile

Scopus 

📜 SIDRA BATOOL: A DEDICATED RESEARCHER AND LEADER

🎓 EARLY ACADEMIC PURSUITS

Sidra Batool, born on January 30, 1997, in Kohat, Khyber Pakhtunkhwa, Pakistan, has pursued a solid academic career. She completed her Matriculation in 2014 with an A1 grade from the BISE Kohat. Continuing her journey, she earned her Intermediate qualification in 2016, achieving an A grade from the BISE Kohat. Her academic foundation, especially in sciences, laid the groundwork for her future research endeavors.

💼 PROFESSIONAL ENDEAVORS

Sidra has demonstrated a diverse range of experiences across academia and business. She has worked as a Research Assistant under Prof. Dr. Sadaf Niaz in the Department of Zoology at Abdul Wali Khan University Mardan. Her key responsibilities included conducting Field Surveys, performing DNA Extraction, PCR Sequencing, and Bioinformatics Analysis. This hands-on experience with advanced laboratory techniques enabled her to contribute significantly to the understanding of tick infestations and related biosecurity measures.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON DNA SEQUENCING

Sidra’s primary research focuses on molecular biology, toxicology, and bioinformatics. Her work emphasizes the taxonomic and molecular characterization of ticks, along with the ecological impacts of various species on livestock. This research is crucial for understanding and controlling tick-borne diseases, especially in rural and under-researched regions of Pakistan. She is proficient in a variety of advanced laboratory techniques, including DNA Extraction, Gel Electrophoresis, PCR, and bioinformatics tools like R Programming, Python, BioEdit, and BEAST. Sidra has also made notable contributions to genomic databases, with several GenBank submissions to her credit, such as OR665376.1, PP565365.1, and PP477083.1.

🌍 IMPACT AND INFLUENCE

Sidra’s research has a direct impact on the field of zoology, particularly in understanding tick infestations and improving livestock health in Pakistan. Her work contributes to sustainable livestock management, helping rural communities mitigate the risks posed by pathogens. Her technical expertise in bioinformatics and molecular biology enables her to explore the genomics of species that directly affect public health and the agricultural economy. Additionally, Sidra’s leadership qualities are evident as she currently manages a team of four, further solidifying her role as a guide and mentor for younger researchers.

🏅 ACADEMIC CITES

Sidra Batool has already started to make her mark in the academic world, with her work receiving citations across various research publications and genomic repositories. Her GenBank submissions and collaborative research papers reflect her growing academic influence. Her participation in conferences and seminars has allowed her to present her findings on a national level, further expanding her recognition in the scientific community.

🏛️ LEGACY AND FUTURE CONTRIBUTIONS

Sidra’s legacy will be defined by her commitment to molecular biology and her efforts to advance research in tick-borne diseases, biosecurity, and ecological conservation. As a young researcher, her potential for contributing to both academic and practical solutions in the field of zoology is immense. In the future, Sidra aspires to expand her research beyond the borders of Pakistan, focusing on international collaborations that address global challenges in zoonotic diseases and biosecurity. With her solid academic background, practical experience, and leadership qualities, she is well-positioned to contribute to global scientific advancements.

✨ PERSONAL SKILLS AND ACHIEVEMENTS

Sidra is proficient in multiple languages, including Pashto, Urdu, and English. Her strong communication skills, both in written and spoken formats, complement her ability to present complex scientific data clearly. She has also garnered a fully funded scholarship through the Ehsaas Undergraduate Scholarship Program for her bachelor’s studies, underscoring her academic excellence. Sidra’s diverse skill set extends to computational tools, where she excels in software like Microsoft Office, FinchTV, Latex, Mesquite, and Figtree, adding value to her research in bioinformatics and computational biology.

📑NOTABLE PUBLICATIONS 

“Infestation prevalence, spatio-temporal distribution, phylogenetic positioning, and pathogen investigation of Argas persicus ticks in domestic hens (Gallus gallus domesticus) from Pakistan” 

  • Authors: Tsai, K.-H., Batool, S., Khan, A.,  Ben Said, M., Khan, A.
  • Journal: Veterinary Parasitology
  • Year: 2024

Giulia Pascolini | Neurodevelopmental Disorders | Best Researcher Award 

Posted on by PencisLeave a Comment on Giulia Pascolini | Neurodevelopmental Disorders | Best Researcher Award 

Dr. Giulia Pascolini | Neurodevelopmental Disorders | Best Researcher Award 

Dermopathic Institute of the Immaculate, IDI-IRCC | Italy 

Author Profile

Scopus 

Orcid ID

Google Scholar

🌟 Biography of Giulia Pascolini, MD, PhD

🎓 EARLY ACADEMIC PURSUITS

Giulia Pascolini's journey in medical science began with a Degree in Medicine from Sapienza University of Rome in 2008, which she completed with honors. Following this, she pursued specialization in Medical Genetics at Tor Vergata University of Rome, graduating with honors in 2015 after five years of in-depth study. Driven by her passion for genetics, Dr. Pascolini went on to earn her Ph.D. in Medical Genetics from Sapienza University in 2019, establishing her expertise in a rapidly advancing field. In 2022, she further expanded her knowledge with a Master of II level in Rare Diseases, also from Sapienza University, solidifying her role as a leading expert in rare genetic disorders.

🩺 PROFESSIONAL ENDEAVORS

Dr. Pascolini's professional career is marked by extensive experience across multiple prestigious institutions. Currently, she is a Clinical Geneticist and head of the Clinical Genetics Service at the Istituto Dermopatico dell'Immacolata (IDI-IRCCS) in Rome, Italy. Since September 2023, she also holds a position as Professor of Medical Genetics at the Faculty of Medicine and Surgery at Tor Vergata University of Rome. Over the years, she has held various roles, including serving as a clinical geneticist at Bambino Gesù Children’s Hospital and a researcher at San Camillo-Forlanini Hospital. Her long-standing commitment to clinical genetics spans over 15 years, with a focus on intellectual disability syndromes, dysmorphology, and developmental disorders.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON NEURODEVELOPMENTAL DISORDERS 

Dr. Pascolini's research primarily centers around Developmental Disorders of Chromatin Remodeling (DDCRs), intellectual disability (ID) syndromes, and genodermatoses. She has played a crucial role in the study of the skin phenotype in rare genetic diseases, and her work on deep learning technologies for diagnosing genetic syndromes using facial phenotype recognition is groundbreaking. Her involvement with FDNA Inc. and the DeepGestalt technology is a testament to her contributions to advancing medical genetics through innovative platforms. She is also a principal investigator for multiple research projects, including studies on rare cutaneous tumors and familial melanoma, with funding of over €47,000 for these projects.

🌍 IMPACT AND INFLUENCE

As a Scientific Board Member of the ADNP Syndrome Italian Association and an editorial board member of the Journal of Pediatric Genetics, Dr. Pascolini has made significant contributions to the broader medical community. Her work has helped shape new approaches to the clinical understanding of complex genetic disorders, particularly in rare diseases and neurodevelopmental syndromes. Through her collaborative efforts with international organizations and her academic roles, she continues to influence both current medical practices and future research directions.

📚 ACADEMIC CITES AND PUBLICATIONS

Dr. Pascolini has authored several impactful works, including her involvement in the DeepGestalt technology article on SETD5-associated intellectual disability published in the Journal of Translational Genetics and Genomics. Her contributions to book chapters, such as her writing on Genomic Copy Number Variants (CNVs) and Autism Spectrum Disorder (ASD), have added substantial value to academic literature. Her expertise has also been recognized through invitations to write for special issues in leading journals, enhancing her standing as a key voice in her field.

🏅 AWARDS AND RECOGNITION

In 2019, Dr. Pascolini was awarded the Franca Dagna Bricarelli Award for her clinical research on genetic mutations associated with the BAF complex. This prestigious award highlights her excellence in medical genetics and clinical research. Her contributions to the field, recognized by peers and institutions alike, reflect her profound impact on the study and treatment of genetic disorders.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

With her leadership in clinical genetics, active research on rare skin diseases, and innovative work in genetic syndrome diagnostics, Dr. Pascolini is poised to continue shaping the future of medical genetics. Her contributions to understanding the genetic basis of intellectual disabilities and her work on cutting-edge diagnostic technologies ensure her legacy as a pioneering figure in genetics. As she continues her role in both clinical and academic settings, her future contributions will likely further advance the study and treatment of rare genetic conditions, helping countless individuals worldwide.

📑NOTABLE PUBLICATIONS 

"The face of Non-photosensitive trichothiodystrophy phenotypic spectrum: A subsequent study on paediatric population" 

  • Authors: Pascolini, G. , Lipari, M. , Gaudioso, F. , Di Zenzo, G. , Didona, B.
  • Journal: Molecular Genetics and Genomic Medicine
  • Year: 2024

"Usmani-Riazuddin syndrome can have a recognizable phenotype: Report of a novel AP1G1 variant" 

  • Authors: Gnazzo, M. , Pascolini, G. , Parlapiano, G. , Novelli, A. , Baban, A.
  • Journal: Clinical Genetics
  • Year: 2024

"Extended phenotypic characterization of a novel Helsmoortel-van der Aa syndrome case series" 

  • Authors: Pascolini, G., Di Zenzo, G., Panebianco, A., Didona, B., Gozes, I.
  • Journal: American Journal of Medical Genetics
  • Year: 2024

"Ectoderm-derived findings in Aymè-Gripp syndrome" 

  • Authors: Pascolini, G., Di Zenzo, G., Morani, P., Didona, B., Panebianco, A.
  • Journal: Journal of Dermatology
  • Year: 2024

"Defining the clinical spectrum of ichthyosis follicularis, atrichia and photophobia clinical association type 1 (IFAP1)" 

  • Authors: Pascolini, G., Fortugno, P., Chandramouli, B., Didona, B., Castiglia, D.
  • Journal: European Journal of Dermatology
  • Year: 2023

Sang Yeon Cho | Molecular Cancer Biology | Best Researcher Award

Posted on by PencisLeave a Comment on Sang Yeon Cho | Molecular Cancer Biology | Best Researcher Award

Dr. Sang Yeon Cho | Molecular Cancer Biology | Best Researcher Award

Chungna National University | South Korea

Author Profile 

Scopus

Google Scholar

BIOGRAPHY OF SANG YEON CHO 🌟

EARLY ACADEMIC PURSUITS 🎓

Sang Yeon Cho embarked on his academic journey at Chungnam National University, where he earned his Bachelor's degree in Biochemistry in 2012. He further pursued an M.S. in Medicine, obtaining his MD degree in 2021. Currently, he is completing his Ph.D. in New Drug Discovery and Development, expected to graduate in February 2025. His strong foundation in the sciences has equipped him with the skills necessary for innovative research in the medical field.

PROFESSIONAL ENDEAVORS 🏥

Currently, Dr. Cho serves as the Vice Director of the Metro Neurosurgery Clinic in Daejeon, South Korea, since October 2022. Prior to this role, he was the Vice Director of Hurisarang Hospital from March 2021 to September 2022. His leadership positions reflect his commitment to advancing medical practice and enhancing patient care.

CONTRIBUTIONS AND RESEARCH FOCUS ON MOLECULAR CANCER BIOLOGY 🔬

As the Director of ChoLab since 2018, Dr. Cho has focused on cancer genomics and new drug discovery. His research has investigated the molecular mechanisms underlying cancer, emphasizing drug resistance and therapeutic targets. He has actively contributed to several labs, including the Neuroglia Lab and the Nano Primo Research Center, showcasing his multidisciplinary approach to tackling complex medical challenges.

IMPACT AND INFLUENCE 🌍

Dr. Cho's work has significantly influenced the field of medical genetics and cancer research. His publications in high-impact journals highlight the clinical significance of his findings, making substantial contributions to understanding cancer prognosis and treatment. Through his research, he aims to bridge the gap between laboratory discoveries and clinical applications, improving patient outcomes.

ACADEMIC CITATIONS 📚

His research output includes numerous peer-reviewed articles in respected journals such as BMC Medical Genomics, Scientific Reports, and BMC Cancer, where he explores topics like drug resistance, immunotherapy biomarkers, and cancer prognosis. His findings have garnered attention and citations within the academic community, underscoring the relevance and quality of his work.

LEGACY 🏆

Dr. Cho's dedication to advancing cancer research and patient care has already left a mark on the field. His innovative approach, exemplified by multiple patents related to AI in healthcare and cancer diagnostics, positions him as a forward-thinking researcher poised to shape future developments in medical science.

FUTURE CONTRIBUTIONS 🔮

Looking ahead, Dr. Cho aims to continue his research in cancer treatment and drug discovery, integrating cutting-edge technologies like artificial intelligence to enhance therapeutic strategies. With his expected Ph.D. completion in 2025, he is set to further expand his contributions to the field and inspire the next generation of medical researchers.

NOTABLE PUBLICATIONS 📑

"A method for the observation of the primo vascular system in the thoracic duct of a rat" 

  • Authors: Kim, S., Jung, S.J., Cho, S.Y., Soh, K.-S., Kim, S.
  • Journal: Evidence-based Complementary and Alternative Medicine
  • Year: 2013

"Protocol for the Observation of the Primo Vascular System in the Lymph Vessels of Rabbits" 

  • Authors: Jung, S.J., Cho, S.Y., Bae, K.-H., ... Song, Y.-K., Soh, K.-S.
  • Journal:  Journal of Acupuncture and Meridian Studies
  • Year: 2012

Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Posted on by PencisLeave a Comment on Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Dr. Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Medical University of South Carolina | United States

Author Profile

Orcid ID

🌟 SAMI I. NASSAR: A DEDICATED JOURNEY IN MEDICINE AND RESEARCH

EARLY ACADEMIC PURSUITS 🎓

Sami I. Nassar began his academic journey at Columbia University, where he majored in Neuroscience and Behavior, graduating Cum Laude in 2019 with an impressive GPA of 3.94/4.00. His academic excellence earned him a place in the Psi Chi International Honor Society in Psychology for his outstanding achievements. This strong foundation in neuroscience laid the groundwork for his future medical career. He is currently pursuing his MD at Wayne State University, School of Medicine, where he is on track to graduate in June 2024, having achieved a Step 2 Score of 258—a testament to his dedication to medical excellence.

PROFESSIONAL ENDEAVORS 👨‍⚕️

Throughout his career, Nassar has actively engaged in clinical and research positions across prestigious institutions. His experience as a Research Fellow at the Medical University of South Carolina since 2024 has enabled him to delve into otolaryngological topics, including vertiginous disorders and suicide risk in head and neck cancer patients. At the Henry Ford Health System and Karmanos Cancer Institute, he contributed to significant research on molecular biomarkers and substance use among cancer patients, helping to push the boundaries of cancer research and patient care. His earlier roles, including work at Generation Next Fertility and Columbia University, demonstrate his practical skills in clinical and laboratory settings, offering a holistic approach to patient care and research. These roles also gave him experience in collaborating with medical professionals and managing clinical trials, which have been integral to his development as a medical researcher.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS AND GENOMICS 🔬

Nassar’s research has focused heavily on otolaryngology, head and neck cancer, and HPV-related carcinomas. His work on identifying molecular biomarkers and risk factors in cancer patients, such as those for suicide and substance use, has been groundbreaking. His research not only seeks to understand the molecular foundations of cancer but also aims to improve the quality of life for cancer patients. His investigations into tinnitus and vertiginous disorders add further depth to his research portfolio, contributing to patient outcomes in the field of ear, nose, and throat (ENT) medicine.

IMPACT AND INFLUENCE 🏆

Nassar's research has been widely recognized within the medical community, as seen through numerous awards. His work has been presented at leading conferences, such as the American Head and Neck Society's 11th International Conference, where he won the 3rd place poster award in the Education/Care Delivery category. His earlier recognition by the American Journal of Gastroenterology in 2021 further highlights his ability to contribute to diverse fields of medicine. His influence extends to peer-reviewed academic journals, where his manuscripts and abstracts have garnered attention, solidifying his reputation as a promising researcher.

ACADEMIC CITES 📚

Nassar’s work has been cited in reputable journals, including Cancer Epidemiology, Biomarkers & Prevention, and the American Journal of Gastroenterology. His published work on topics like teduglutide therapy for Short Bowel Syndrome and cancer epidemiology reflects his ability to contribute to high-impact scientific literature. These citations, alongside his ongoing manuscripts on suicide and substance use in cancer patients, illustrate his influence on ongoing medical research.

LEGACY AND FUTURE CONTRIBUTIONS 🌍

As a young and promising researcher, Nassar is poised to make even more significant contributions to the field of medicine. His research on biomarkers and immunochemotherapy for cancer treatment, as well as his ongoing investigation into the psychological aspects of cancer care, will likely have a lasting impact on both academic research and clinical practice. His focus on improving patient quality of life through research on mental health and substance use demonstrates his commitment to a holistic approach to medicine, one that integrates both physical and mental health outcomes. His legacy will undoubtedly include shaping future practices in otolaryngology, head and neck oncology, and biomolecular cancer therapy. With his continued drive and dedication, Nassar’s future contributions to medical science promise to push boundaries and pave the way for innovative treatments and care models.

NOTABLE PUBLICATIONS 📑

"S3030 Safety and Efficacy of Teduglutide Therapy for Management of Short Bowel Syndrome After Intestinal Transplantation" 

  • Authors: Sami I. Nassar; Syed-Mohammed Jafri
  • Journal: American Journal of Gastroenterology
  • Year: 2021

"Abstract C067: Disparities in health literacy in patients with head and neck cancer: Considerations for understanding" 

  • Authors: Aleksandra Vidovich; Amy Williams; Samantha H. Tam; Mary K. Miller; Maria Olex; Sami Nassar; Alex Rodriguez; Eric Adjei Boakye
  • Journal: Cancer Epidemiology, Biomarkers & Prevention
  • Year: 2023

"The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine"

  • Authors: Sami I. Nassar; Amber Suk; Shaun A. Nguyen, MD; Dauren Adilbay; John Pang; Cherie-Ann Nathan
  • Journal: Cancer
  • Year: 2024

Bassam Al-Naami | Cognitive Neuropsychiatry | Excellence Award(Any Scientific Field)

Posted on by PencisLeave a Comment on Bassam Al-Naami | Cognitive Neuropsychiatry | Excellence Award(Any Scientific Field)

Prof Bassam Al-Naami | Cognitive Neuropsychiatry | Excellence Award(Any Scientific Field)

The Hashemite University | Jordan 

Author Profile

Scopus

Orcid ID

Google Scholar

📘 BASSAM AL-NAAMI, PH.D. – BIOGRAPHY

🎓 EARLY ACADEMIC PURSUITS

PH.D. IN MEDICAL ELECTRONICS AND ERGONOMICS From 1997 to 2000, Dr. Bassam Al-Naami pursued his Ph.D. at the Saint Petersburg State Electrotechnical University (LETI), Russia. His research was centered on Interaction Efficiency of Operational Virtual Reality Systems with an Operator, a project merging biomedical engineering and television and video engineering. His doctoral work emphasized ergonomics, human factors, and the integration of technology to improve operator interaction in virtual systems. VISITING RESEARCH FELLOWSHIP IN SIGNAL & IMAGE PROCESSING From 2001 to 2003, Dr. Al-Naami completed a Visiting Research Fellowship at the University of Sussex, Brighton, UK. He collaborated with notable researchers, including Dr. John Torry, Dr. Mark English, and Prof. Richard Vincent, focusing on wavelet domain signal processing. DIPLOMA IN BIOMEDICAL ENGINEERING/MEDICAL ELECTRONICS His foundational academic journey began at Stavropol State Technical University, Russia, where he earned a Five-Year Honors Diploma in Biomedical Engineering and Medical Electronics (1992–1997). This laid the groundwork for his future in medical instrumentation and signal processing.

💼 PROFESSIONAL ENDEAVORS

PROFESSOR & DEPARTMENT CHAIR Currently, Dr. Al-Naami holds the position of Professor and Department Chair of Biomedical Engineering at Hashemite University (HU) in Jordan. His career spans over two decades, during which he also served as Vice Dean of Student Affairs (2014–2015) and Dean Assistant of Engineering Faculty (2010–2012). ABET ACCREDITATION LEADER Dr. Al-Naami has been deeply involved in academic accreditation efforts, serving as the ABET Coordinator at Hashemite University. His leadership in developing academic programs, ensuring quality standards, and facilitating ABET accreditation for the Biomedical Engineering department at HU has significantly enhanced the institution’s academic reputation. Additionally, he was pivotal in founding the Master’s Program in Biomedical Engineering at HU during the academic year 2022-2023. ADMINISTRATIVE ROLES & TEACHING Beyond accreditation, Dr. Al-Naami has served on multiple academic committees, contributed to curriculum development, and mentored over 70 final-year engineering projects. He has extensive teaching experience in medical imaging, biomedical instrumentation, and advanced signal processing.

🧬 CONTRIBUTIONS AND RESEARCH FOCUS ON COGNITIVE NEUROPSYCHIATRY

SIGNAL AND IMAGE PROCESSING Dr. Al-Naami's research has a notable focus on signal and image processing in clinical settings, exploring:

  • ECG, cardiac ischemia, and arrhythmias
  • Automated detection of sleep apnea
  • Neurological disorders like Alzheimer’s and multiple sclerosis
  • Cancer detection via CT and MRI images

MEDICAL INSTRUMENTATION & NON-INVASIVE TECHNOLOGIES He has advanced the development of non-invasive diagnostic tools including devices for:

  • Hemoglobin measurement
  • Lung sound analysis
  • Wound healing automation systems

His pioneering work in field-programmable gate arrays (FPGA) for medical applications has contributed to real-time health monitoring systems. ERGONOMICS & VIRTUAL REALITY Dr. Al-Naami has been at the forefront of ergonomics and virtual reality (VR) research, using haptic devices and VR systems to improve training for medical professionals. His research into the physiological impacts of VR, including visual and muscle fatigue, has influenced both the medical and industrial sectors.

🌍 IMPACT AND INFLUENCE

Dr. Al-Naami’s contributions have significantly impacted medical technology and biomedical engineering across the Middle East and internationally. His leadership in academic accreditation and program development has shaped the next generation of biomedical engineers in Jordan. Through his research, he has improved diagnostic techniques in critical areas such as cancer detection, heart disease, and neurology. His collaboration with global institutions like the University of Sussex and the Jordanian Engineering Association further amplifies his influence.

📊 ACADEMIC CITES

Dr. Al-Naami's work has been widely cited in academic and clinical research papers. His findings on non-invasive medical diagnostics, image processing, and signal analysis are frequently referenced in journals related to biomedical engineering and medical instrumentation.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

AWARDS & RECOGNITION
Dr. Al-Naami has been recognized for his outstanding contributions with multiple accolades, including:

  • IEEE Senior Membership (2023)
  • Excellence in Scientific Research Award from Hashemite University (2013/2014)
  • Best Project Award at Saint Petersburg LETI (1999)

His legacy in shaping the biomedical engineering field through teaching, research, and administrative leadership is remarkable. Moving forward, Dr. Al-Naami aims to continue his research in AI-driven medical diagnostics and expand his work in non-invasive medical devices. FUTURE CONTRIBUTIONS As technology evolves, Dr. Al-Naami’s ongoing projects in deep learning for medical imaging and thermographic analysis for hemoglobin levels will likely redefine diagnostic practices. His focus on IoT in healthcare is set to create innovative solutions for remote patient monitoring and improved healthcare delivery.

📚 TEACHING EXPERIENCE

Dr. Al-Naami has taught a diverse array of undergraduate and postgraduate courses, including:

  • Biomedical Instrumentation I & II
  • Medical Imaging Modalities
  • Digital Image Processing
  • Medical Device Design & Development

His commitment to education is evident in his student mentorship, advising over 70 final-year projects across biomedical, electrical, and mechanical engineering disciplines.

🔬 RESEARCH PROJECTS

Dr. Al-Naami has spearheaded numerous funded research projects. Key projects include:

  • Non-invasive hemoglobin measurement using advanced image processing and deep learning
  • Kidney stone detection using artificial intelligence
  • Automated hand dexterity monitoring systems for post-stroke patients

His collaborations with institutions such as Al-Bashir Government Hospital and Jordan University Hospital have enhanced clinical research applications in Jordan.

🌟 PROFESSIONAL AFFILIATIONS

Dr. Al-Naami is a Senior Member of IEEE and a member of the Jordanian Engineering Association. He has actively contributed to professional societies, such as the IEEE Engineering in Medicine and Biology Society, playing a vital role in advancing the field of biomedical engineering globally.

📑NOTABLE PUBLICATIONS 

"Electromyography Monitoring Systems in Rehabilitation: A Review of Clinical Applications, Wearable Devices and Signal Acquisition Methodologies" 

  • Authors: Al-Ayyad, M. , Owida, H.A. , De Fazio, R. , Al-Naami, B. , Visconti, P.
  • Journal: Electronics
  • Year: 2023

"IoT Solutions and AI-Based Frameworks for Masked-Face and Face Recognition to Fight the COVID-19 Pandemic" 

  • Authors: Al-Nabulsi, J. , Turab, N. , Owida, H.A. , ... De Fazio, R. , Visconti, P.
  • Journal: Sensors
  • Year: 2023

"Improved recovery of cardiac auscultation sounds using modified cosine transform and LSTM-based masking"

  • Authors: Al-Zaben, A. , Al-Fahoum, A. , Ababneh, M. , Al-Naami, B. , Al-Omari, G.
  • Journal: Medical and Biological Engineering and Computing
  • Year: 2024

"Advanced Low-Pass Filters for Signal Processing: A Comparative Study on Gaussian, Mittag-Leffler, and Savitzky-Golay Filters"

  • Authors: Rawash, Y.Z. , Al‐Naami, B. , Alfraihat, A. , Owida, H.A.
  • Journal: Mathematical Modelling of Engineering Problems
  • Year: 2024

"Automated Lung Cancer Diagnosis Applying Butterworth Filtering, Bi-Level Feature Extraction, and Sparce Convolutional Neural Network to Luna 16 CT Images"

  • Authors: Gharaibeh, N.Y. , De Fazio, R. , Al-Naami, B. , Al-Hinnawi, A.-R. , Visconti, P.
  • Journal: Journal of Imaging
  • Year: 2024

Ofon Elvis Amih | Infectious Diseases | Best Researcher Award

Posted on by PencisLeave a Comment on Ofon Elvis Amih | Infectious Diseases | Best Researcher Award

Dr. Ofon Elvis Amih | Infectious Diseases | Best Researcher Award

University of Buea | Cameroon

Author Profile

Scopus

Biography of Dr. Ofon Elvis Amih 🌍🧬

EARLY ACADEMIC PURSUITS 🎓

Dr. Ofon Elvis Amih’s academic journey is rooted in his commitment to biochemistry, starting with his undergraduate studies at the University of Dschang, Cameroon. From 2006 to 2010, he pursued a Bachelor of Science in Biochemistry with a specialty in Clinical Biochemistry. His passion for this field led him to continue his studies at the same institution, where he earned a Master of Science in Biochemistry between 2010 and 2013, further specializing in Clinical Biochemistry. In 2014, Dr. Amih embarked on his doctoral studies, culminating in a PhD in Biochemistry with a specialty in Clinical Biochemistry from the University of Dschang in 2019. His doctoral research solidified his expertise in biochemistry and set the stage for his future contributions to the field.

PROFESSIONAL ENDEAVORS AND TEACHING 📚

Dr. Amih’s career in academia began at the University of Dschang, where he served as a Graduate Teaching Monitor from 2014 to 2021. In this role, he assisted in tutorials, practical lessons, and exam invigilation. His teaching career advanced further when he joined the University of Buea as an Assistant Lecturer at the Faculty of Health Sciences in October 2021. His work at the University of Buea involves mentoring students and imparting valuable knowledge in the field of biochemistry. In addition to teaching, Dr. Amih engaged in postdoctoral research with the TrypanoGEN+ Consortium from 2019 to 2022, where he worked on groundbreaking research related to genome-wide association studies (GWAS). Furthermore, he became a Bioinformatics Fellow with H3Abionet/H3Africa, contributing to the intersection of bioinformatics and biochemistry through collaborative projects across Africa.

CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES🔬

Dr. Amih's research is deeply focused on the genetic markers associated with Human African Trypanosomiasis (HAT). His manuscript, currently in press, titled "A Genome-wide association study reveals novel genetic markers associated with Human African Trypanosomiasis," marks a significant contribution to understanding this tropical disease. His research work bridges biochemistry and bioinformatics, with an emphasis on using advanced genomic tools to address pressing health issues in Africa.

IMPACT AND INFLUENCE 🌟

Dr. Amih has had a considerable influence in his field, particularly through his involvement in internationally recognized initiatives like the TrypanoGEN+ Consortium and H3Abionet/H3Africa. His contributions extend beyond research, as he is also shaping future generations of scientists and biochemists through his academic roles. His work has impacted the global scientific community, with his insights contributing to scientific journals and conferences worldwide. He has actively participated in numerous workshops and conferences, from local events in Cameroon to international collaborations, such as the H3ABioNet Online ‘Introduction to Bioinformatics’ training course in South Africa.

ACADEMIC CITATIONS AND PUBLICATIONS🏅

Dr. Amih’s academic impact is further validated by his involvement in journal review activities for reputable publications such as Plos Computational Biology and the Journal of Bioscience and Medicine. His own manuscripts, particularly the upcoming publication on genetic markers for Human African Trypanosomiasis, are anticipated to contribute valuable citations in the field of clinical biochemistry and tropical disease research.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

As Dr. Amih continues his academic and research endeavors, his legacy is likely to be defined by his contributions to both biochemistry and bioinformatics. His ongoing role at the University of Buea, coupled with his research collaborations across Africa, ensures that his work will leave a lasting impact on the scientific community, particularly in the areas of neglected tropical diseases and genetic research. Looking ahead, Dr. Amih is poised to expand his contributions through more collaborative research projects, potentially leading future generations of scientists and continuing to address critical health challenges in Africa. His deep expertise in both biochemistry and bioinformatics uniquely positions him as a leader in these intertwined disciplines.

NOTABLE PUBLICATIONS 📑

"High Levels of Genetic Diversity within Nilo-Saharan Populations: Implications for Human Adaptation" 

  • Authors: Mulindwa, J., Noyes, H., Ilboudo, H., Ahouty, B., & Kabore, J.
  • Journal: Human Genetics
  • Year: 2020

"Copy number variation in human genomes from three major ethno-linguistic groups in Africa" 

  • Authors: Nyangiri, O.A. , Noyes, H. , Mulindwa, J. ,Hertz-Fowler, C. , Matovu, E.
  • Journal: Genomics
  • Year: 2020

"Molecular identification of different trypanosome species in tsetse flies caught in the wildlife reserve of Santchou in the western region of Cameroon"

  • Authors: Kamdem, C.N. , Tiofack, A.A.Z. , Mewamba, E.M. , Gomseu, E.B.D. , Simo, G.
  • Journal: Parasitology Research
  • Year: 2020

"Association between polymorphisms of IL4, IL13, IL10, STAT6 and IFNG genes, cytokines and immunoglobulin E levels with high burden of Schistosoma mansoni in children from schistosomiasis endemic areas of Cameroon"

  • Authors: Mewamba, E.M. , Noyes, H. , Tiofack, A.A.Z. , MacLeod, A. , Simo, G.
  • Journal: Genetics and Evolution
  • Year: 2023

"Evaluation of ITS1 rDNA primers for the detection and identification of African trypanosomes in mammalian hosts and tsetse flies."

  • Authors: Ofon, E.A. , Metiadjoue, M.C.C. , Kante, S.T. ,Fogue, S.P. , Simo, G.
  • Journal: Acta Tropica
  • Year: 2024

Jun Tian | Movement Disorder | Best Researcher Award

Posted on by PencisLeave a Comment on Jun Tian | Movement Disorder | Best Researcher Award

Dr. Jun Tian | Movement Disorder | Best Researcher Award

2nd Affiliated Hospital, Zhejiang University, School of Medicine | China

🧠 JUN TIAN: A PIONEER IN NEUROLOGICAL RESEARCH

EARLY ACADEMIC PURSUITS 📚

Jun Tian began his academic journey at Zhejiang University, one of the leading institutions in China, where he obtained his Bachelor's degree in Clinical Medicine (1999-2004). His passion for neurology led him to pursue further specialization, earning a Master's degree in Neurology (2004-2006) from the same institution. During these formative years, he developed a strong foundation in the study of neurological disorders, setting the stage for his future contributions to the field. His academic pursuits culminated in a Ph.D. in Neurology (2009-2013), where he focused on the molecular and cellular mechanisms behind neurodegenerative diseases, particularly Parkinson’s disease.

PROFESSIONAL ENDEAVORS 👩‍⚕️

Jun Tian's professional career took flight in 2006, when he began working as a Resident in the Department of Geriatrics at the Second Affiliated Hospital, School of Medicine, Zhejiang University. His work during this time exposed him to a wide range of neurological conditions affecting older adults, deepening his clinical expertise. In 2009, he transitioned to a Fellowship position in the Department of Neurology at the same institution. In this role, he gained further clinical experience while also pursuing cutting-edge research in neurological disorders, with a particular focus on movement disorders such as Parkinson’s disease and Huntington’s disease.

CONTRIBUTIONS AND RESEARCH FOCUS ON MOVEMENT DISORDER 🔬

Jun Tian’s research has primarily centered on the mechanisms behind neurodegenerative diseases, particularly Parkinson's disease and Huntington’s disease. His work has explored key issues such as mitochondrial dysfunction in neurons and the role of specific neural pathways in disease progression. He has presented his research at multiple prestigious international conferences, including:

  • 2013 at the 17th International Congress of Parkinson’s Disease and Movement Disorders in Australia, where he presented a guided poster tour on mutant Huntingtin protein’s impact on mitochondrial axonal transport in cultured hippocampal neurons.
  • 2014 at the 4th Asian and Oceanian Parkinson's Disease and Movement Disorders Congress in Thailand, where he discussed the effects of optical stimulation of glutamatergic afferent fibers in neural pathways.

IMPACT AND INFLUENCE 🌍

Jun Tian’s research has made significant contributions to the understanding of how neurodegenerative diseases impair neuronal function. His work on mitochondrial axonal transport has provided new insights into the mechanisms by which diseases like Huntington’s affect neuron health, potentially opening new avenues for therapeutic interventions. In addition to his clinical and research roles, he has been recognized for his academic excellence with the prestigious Gekequan Scholarship from Zhejiang University in 2011. This award reflects the high regard his peers and mentors have for his dedication and talent.

ACADEMIC CITATIONS AND SCHOLARLY IMPACT 🏅

Jun Tian’s research, presented at leading international conferences, has been well-received in the academic community. Although specific details about his publications are limited, his work on Parkinson’s disease and mitochondrial dysfunction has the potential to influence future research in these areas, contributing to the growing body of knowledge on how neurodegenerative diseases can be treated or managed.

LEGACY AND FUTURE CONTRIBUTIONS 🌟

Jun Tian is well on his way to establishing a lasting legacy in the field of neurology, particularly in the study of neurodegenerative diseases. His work has already made significant strides in understanding how neurological disorders affect cellular mechanisms, and future research could lead to breakthroughs in treatment strategies for patients suffering from these debilitating conditions. Looking forward, Jun Tian’s contributions to neurology will likely continue to grow, both through his clinical work and his research efforts. His participation in international forums and collaborations with leading researchers will further enhance his impact in the field, ensuring that his legacy endures for future generations of neurologists and researchers.

NOTABLE PUBLICATIONS 📑

"Alzheimer Disease and Epilepsy: A Mendelian Randomization Study" 

  • Authors: Fang, Y., Si, X., Wang, J., Zhang, B., Pu, J
  • Journal: Neurology
  • Year: 2023

"The clinical characteristics of neuronal intranuclear inclusion disease and its relation with inflammation" 

  • Authors: Yan, Y., Cao, L., Gu, L., Zhang, B., Zhao, G.
  • Journal: Neurological Sciences
  • Year: 2023

"Elevated serum anti-Saccharomyces cerevisiae antibody accompanied by gut mycobiota dysbiosis as a biomarker of diagnosis in patients with de novo Parkinson disease"

  • Authors: Chen, Y., Zhang, L.-Y., Fang, Y., Zhang, B.-R., Pu, J.-L.
  • Journal: European Journal of Neurology
  • Year: 2023

"Cytokine and chemokine map of peripheral specific immune cell subsets in Parkinson’s disease"

  • Authors: Jiang, S.-S., Wang, Y.-L., Xu, Q.-H., Tian, J., Pu, J.-L.
  • Journal: npj Parkinson's Disease
  • Year: 2023

"The longitudinal volumetric and shape changes of subcortical nuclei in Parkinson’s disease"

  • Authors: Yang, W., Bai, X., Guan, X., Pu, J., Tian, J.
  • Journal: Scientific Reports
  • Year: 2024

Kuangyn Yen | Gene Regulation and Epigenetics | Best Researcher Award

Posted on by PencisLeave a Comment on Kuangyn Yen | Gene Regulation and Epigenetics | Best Researcher Award

Dr. Kuangyn Yen | Gene Regulation and Epigenetics | Best Researcher Award

Chinese Academy of Medical Sciences and Peking Union Medical College | China 

Author Profile

Scopus 

Orcid ID

📘 KUANGYU YEN, PhD: PIONEER IN TRANSCRIPTION REGULATION AND CHROMATIN DYNAMICS

🎓 EARLY ACADEMIC PURSUITS

Kuangyu Yen's academic journey began at National Taiwan University, where he earned a Bachelor of Science in Horticulture (Molecular Biology Unit) in 1998. His passion for molecular biology led him to pursue advanced degrees at the University of Manchester, UK, where he completed both an MRes (2001) and a Ph.D. in Molecular Biology (2005). His doctoral research laid the foundation for his expertise in transcription regulation, setting the stage for his future research endeavors.

💼 PROFESSIONAL ENDEAVORS

Dr. Yen's professional career is marked by a blend of international experiences and prestigious appointments:

  • Chinese Academy of Medical Sciences & Peking Union Medical College (2022-present): Researcher.
  • Southern Medical University (2014-2022): Professor, where he contributed significantly to the academic and research community in Guangzhou, China.
  • Pennsylvania State University (2008-2014): Post-doctoral fellow and later Research Assistant Professor, expanding his expertise in transcription regulation and chromatin dynamics.
  • University of Washington (2005-2007): Post-doctoral fellow, further deepening his understanding of molecular biology at the intersection of chromatin and transcription.
  • National Taiwan University (1998-2000): Research Assistant, where his scientific curiosity began to flourish.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON GENE REGULATION AND EPIGENETICS

Dr. Yen's research focus is on transcription regulation and its influence on cell fate determination, particularly through chromatin dynamics. His innovative use of bioinformatic tools, CRISPR/Cas9-engineered depletion, and biochemical reconstitution has made him a leader in understanding how chromatin regulates transcription in a spatiotemporal manner. His research has significant implications for disease diagnosis and treatment, especially in preventing precancerous cells from progressing into cancer cells. One of his notable contributions is the development of a two-tipping point model, which helps explain how cell fate transitions. This model has potential applications in both basic research and clinical practice, offering insights into the molecular mechanisms of various diseases.

🌍 IMPACT AND INFLUENCE

Dr. Yen’s work has been internationally recognized, and he has secured multiple high-profile grants and awards, such as the Thousand Youth Talents Award and the Outstanding Youth Award. His research has attracted funding from the National Natural Science Foundation of China, the National Key Research and Development Program of China, and international collaborations such as the France-China Joint Research Projects Program. His influence extends to key speaking engagements and workshops in the field of epigenetics and hematopoiesis at global institutions, including John Hopkins University.

📊 ACADEMIC CITATIONS

With several publications to his name, Dr. Yen’s work is well-cited in the scientific community, reinforcing his status as an influential researcher in molecular biology. His contributions to understanding transcription regulation and chromatin dynamics continue to resonate, particularly in the areas of epigenetics and hematopoiesis.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Kuangyu Yen’s legacy will likely center on his pioneering research into how chromatin structure affects transcriptional regulation and cell fate transitions. His use of cutting-edge tools like CRISPR/Cas9 and bioinformatics has laid the groundwork for future advancements in cancer prevention and molecular diagnostics. Moving forward, Dr. Yen’s ongoing research at the Chinese Academy of Medical Sciences is poised to further influence how scientists understand and manipulate transcription regulation. His editorial role at Communication Biology (2024-2026) and other professional activities suggest that his contributions to the field are far from over.

🚀 AWARDS AND PROFESSIONAL RECOGNITION

  • National Natural Science Foundation of China: Multiple grants for outstanding research, totaling over 500,000 USD.
  • Thousand Youth Talents Award: A prestigious recognition with funding of 0.67 million USD.
  • Numerous invited talks at top-tier institutions and international conferences.

Kuangyu Yen’s continuous dedication to his research and the academic community positions him as a transformative figure in molecular biology, with future contributions set to further shape the field.

📅 FUTURE HIGHLIGHTS

Dr. Yen’s ongoing projects and his active engagement with the scientific community, including participation in international editorial boards and professional panels, indicate that his work will continue to shape the future of molecular biology research for years to come.

📑NOTABLE PUBLICATIONS 

"RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation" 

  • Authors: Liu, S., Yang, J., Sun, G., Yen, K., & Lu, T. (2021).
  • Journal: Molecular Biosciences
  • Year: 2021

"Chemical screening reveals Ronidazole is a superior prodrug to Metronidazole for nitroreductase-induced cell ablation system in zebrafish larvae" 

  • Authors: Lai, S., Kumari, A., Liu, J., Yen, K., & Xu, J.
  • Journal: Genetics and Genomics
  • Year: 2021

"Comprehensive understanding of Tn5 insertion preference improves transcription regulatory element identification"

  • Authors: Zhang, H., Lu, T., Liu, S., Chen, F., & Yen, K.
  • Journal: NAR Genomics and Bioinformatics
  • Year: 2021

"Functional Verification of Novel ELMO1 Variants by Live Imaging in Zebrafish"

  • Authors: Xue, R., Wang, Y., Wang, T., Liu, Q., & Xu, J.
  • Journal: Frontiers in Cell and Developmental Biology
  • Year: 2021

"SPI1-KLF1/LYL1 axis regulates lineage commitment during endothelial-to-hematopoietic transition from human pluripotent stem cells"

  • Authors: Qu, K., Mo, S., Huang, J., Shen, J., & Yen, K.
  • Journal: iScience
  • Year: 2024

Flavio Faletra | Cardiovascular Genetics and Genomics | Best Researcher Award 

Posted on by PencisLeave a Comment on Flavio Faletra | Cardiovascular Genetics and Genomics | Best Researcher Award 

Dr. Flavio Faletra | Cardiovascular Genetics and Genomics | Best Researcher Award 

University Health Authority of Central Friuli | Italy

Author Profile

Scopus
Orcid ID

Biography of Flavio Faletra: A Leader in Medical Genetics 🧬

EARLY ACADEMIC PURSUITS 🎓

Flavio Faletra began his distinguished academic journey at the University of Trieste, where he earned a Degree in Medicine and Surgery in 2005. He further specialized in Medical Genetics at the same institution, completing his specialization in 2009. Demonstrating a strong commitment to his field, Faletra pursued advanced education with a Second-level Master’s degree in Clinical Genetics from the University of Siena in 2011. His foundational academic achievements laid the groundwork for a career focused on the intersection of genetics and clinical medicine.

PROFESSIONAL ENDEAVORS 🏥

Flavio Faletra has held multiple pivotal roles in medical genetics. Since August 2023, he has been an Expert in Genetics at the Regional Health Coordination Agency (ARCS) in Friuli Venezia Giulia, Italy. Alongside his expert role, he has been a University Lecturer on contract at the University of Trieste from 2018 to 2023, contributing to the academic growth of students in the field of genetics. His professional journey includes numerous positions as a Medical Director I Level in Medical Genetics, starting with the IRCCS Burlo Garofolo (2013–2017) and progressing through roles in University Health Authority Friuli Centrale and IRCCS Burlo Garofolo until his current position, reflecting his leadership in the medical genetics field.

CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR GENETICS AND GENOMICS  🔬

Faletra’s research focus spans various critical areas of medical genetics, from pediatric endocrinology to rare genetic diseases. He has contributed extensively to genetic counseling and clinical genetics, with a strong emphasis on pediatric genetic disorders. His work as a Thesis Co-Surveyor and PhD Supervisor at the University of Trieste demonstrates his dedication to nurturing the next generation of geneticists. Through courses such as the Genetic Consulting in Medical Genetics Specialization School, he has shaped the landscape of medical genetics education. His involvement in pediatric endocrinology through ADE courses has brought syndromic genetic disorders to the forefront, significantly impacting the medical community’s approach to these conditions.

IMPACT AND INFLUENCE 🌍

Faletra’s influence extends beyond academia into clinical practice, where his expertise has helped shape genetic diagnostic strategies across Italy. His participation in national conferences, such as the National Congress of Human Genetics and seminars on genetic syndromes and diagnostics, marks him as a key figure in Italian medical genetics. Faletra's teaching and research efforts have particularly impacted the areas of growth retardation, fetal malformations, and syndromic genetic disorders, positioning him as a central figure in advancing genetic medicine in pediatrics.

ACADEMIC CITES 📚

Flavio Faletra's work has been cited in numerous academic publications, with topics ranging from genetic diagnostic methods to therapeutic approaches for rare genetic disorders. His research in exome sequencing and next-generation sequencing techniques has had a broad impact, being referenced widely in the fields of human genetics and pediatric medicine.

LEGACY AND FUTURE CONTRIBUTIONS 🏅

Faletra’s legacy lies in his dedication to medical genetics, particularly in the areas of pediatric syndromic diseases and clinical genetics. His contribution to education, research, and clinical practice has left an indelible mark on the field. Looking ahead, his ongoing role as an expert and lecturer promises continued contributions to genomic medicine and the advancement of personalized treatment for genetic disorders. Through his continuous involvement in research, teaching, and clinical practice, Faletra remains at the forefront of innovation in medical genetics, with the potential to further revolutionize the diagnosis and treatment of complex genetic diseases.

NOTABLE PUBLICATIONS 📑

"SRSF1 haploinsufficiency is responsible for a syndromic developmental disorder associated with intellectual disability" 

  • Authors: Bogaert, E., Garde, A., Gautier, T., Dermaut, B., Vitobello, A.
  • Journal: American Journal of Human Genetics
  • Year: 2023

"Haploinsufficiency as a Foreground Pathomechanism of Poirer-Bienvenu Syndrome and Novel Insights Underlying the Phenotypic Continuum of CSNK2B-Associated Disorders" 

  • Authors:Di Stazio, M., Zanus, C., Faletra, F., d’Adamo, A.P., Musante, L.
  • Journal: Genes
  • Year: 2023

"A new neurodevelopmental disorder linked to heterozygous variants in UNC79"

  • Authors: A., Liu, Z., Luo, S., Liao, W., & Ren, D.
  • Journal: Genetics in Medicine
  • Year: 2023

"The clinical impact of the first-trimester nuchal translucency between the 95th–99th percentiles"

  • Authors: Fantasia, I., Catagini, S., Zamagni, G., Feresin, A., & Stampalija, T.
  • Journal: Prenatal Diagnosis
  • Year: 2023

"A bird’s eye view on the use of whole exome sequencing in rare congenital ophthalmic diseases"

  • Authors: Zucco, J., Baldan, F., Allegri, L., Damante, G., Mio, C.
  • Journal: Journal of Human Genetics
  • Year: 2024

Gang liu | Cancer | Best Researcher Award

Posted on by PencisLeave a Comment on Gang liu | Cancer | Best Researcher Award

Prof Gang liu | Cancer | Best Researcher Award

Gansu Provincial Center for Disease Control and Prevention | China

Author Profile

Scopus

Gang Liu: Pioneer in Radiobiology and Preventive Medicine ⚛️

EARLY ACADEMIC PURSUITS 🎓

Gang Liu began his academic journey at Lanzhou University, where he pursued a PhD in preventive medicine. His graduation in 1997 marked the beginning of a career dedicated to understanding the impacts of radiation on health. His academic training in preventive medicine provided the foundation for his future contributions to radiobiology and public health, particularly in the context of disease control and prevention.

PROFESSIONAL ENDEAVORS 🏢

After obtaining his PhD, Gang Liu embarked on a distinguished career at the Gansu Provincial Center for Disease Control and Prevention. His professional focus has been on the intersection of radiobiology, immunology, and tumor screening. In 2019, his registration as a health physicist signaled a significant milestone. He became the technical lead for a groundbreaking study on low-dose dose-effect relationships, a critical area in radiation therapy and safety. His expertise in radiation protection and therapy has earned him a prominent position within the medical research community.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER🧬

Gang Liu's research primarily revolves around radiobiology and radiation protection in therapy. His technological advancements in biological dose estimation are considered cutting-edge within China and recognized internationally. One of his significant contributions was revising the 2011 IAEA Manual based on findings from his studies on radiological sensitivity and dose rates. This revision, coupled with his publications in the FASEB Journal, has made Liu a leading figure in radiation science. His work in chromosomal aberration analysis and developing noninvasive techniques for early-stage cancer screening underscores his innovative approach to medical research.

IMPACT AND INFLUENCE 🌍

Gang Liu's influence extends beyond national borders. His research on radiological sensitivity and dose rates, especially in the context of cancer screening and radiation therapy, has set new benchmarks in the field. The international recognition of his work, particularly his advancements in biological dose estimation and contributions to global radiation protection protocols, underscores his importance in radiobiology. His work is used by institutions worldwide to improve radiation safety standards and enhance cancer diagnostic techniques.

ACADEMIC CITATIONS 📚

His pioneering research has been published in prestigious journals such as the FASEB Journal, one of the top international platforms for scientific contributions. The citations of his work in radiological sensitivity, chromosomal aberration analysis, and cancer screening techniques reflect his deep impact on the scientific community, with his methods influencing both practical applications in healthcare and further research.

LEGACY AND FUTURE CONTRIBUTIONS 🔬

Gang Liu’s legacy will likely be defined by his leadership in advancing radiation protection technology and cancer screening techniques. As an innovator in radiological health, his influence will continue to grow through future contributions to radiation therapy safety, noninvasive cancer detection, and international health standards. His ongoing work in exploring new methods for biological dose estimation will further establish his standing as a key figure in the evolution of radiation medicine.

NOTABLE PUBLICATIONS 📑

"Study of Low-Dose Radiation Workers Ionizing Radiation Sensitivity Index and Radiation Dose-Effect Relationship" 

  • Authors: Liu, G., Zhang, R., Li, Y., Liu, Y.Y., Zhang, X.
  • Journal: Health Physics
  • Year: 2022

"Revision of cytogenetic dosimetry in the IAEA manual 2011 based on data about radio-sensitivity and dose-rate findings contributing" 

  • Authors:Liu, G.
  • Journal: FASEB Journal
  • Year: 2022

"Thyroid dose assessments due to inhalation of 131I for nuclear medicine workers"

  • Authors: Liu, G., Li, Y., Zhang, H., Niu, L.M., Zhang, R.
  • Journal: Frontiers in Public Health
  • Year: 2022

"Study of Indicators for Early and Rapid Diagnosis of Radiation Injury Is the Most Important in Patients With Cancer During Radiotherapy"

  • Authors: Liu, G., Niu, L.-M., Wang, L.-Q., Liu, Y.-Y., Zhang, R.
  • Journal: Dose-Response
  • Year: 2020

"Chromosomal aberration analysis: Novel noninvasive techniques for early-stage cancer screening"

  • Authors: Liu, G.
  • Journal: Clinica Chimica Acta
  • Year: 2024